 |
인쇄하기
취소
|
MFDS distributes safety letter about epilepsy and bipolar treatment ‘lamotrigine’
On the 2nd, the Ministry of Food and Drug Safety(Minister Young-Jin Ryu, MFDS) announced to distribute a safety letter which has health care providers stop prescribing and dispensing once a patient is suspicious of having hemophagocytic lymphohistiocytosis(HLH) with immediate diagnosis on patients taking ‘lamotrigine’ for the treatment of epilepsy and bipolar and showing signs of fever and/or r...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.